Literature DB >> 23873096

Progress against laryngeal cancer in The Netherlands between 1989 and 2010.

Boukje A C van Dijk1, Henrike E Karim-Kos, Jan Willem Coebergh, Henri A M Marres, Esther de Vries.   

Abstract

Cancer of the larynx is a frequently occurring head and neck cancer in The Netherlands. The main risk factors are smoking and excessive alcohol consumption. The aim of our study was to evaluate the progress against laryngeal cancer by studying trends in incidence, mortality and survival in The Netherlands. All patients in The Netherlands Cancer Registry diagnosed with invasive primary squamous cell carcinoma of the larynx during the period 1989-2010 were included for analysis. Time trends in incidence, mortality, treatment and survival were described for the total group and stratified by sex and subsite: glottis, supraglottis and subglottis. The most frequently affected subsite for men was the glottis (69%) and for women the supraglottis (55%). Glottic cancer was diagnosed at lower stages than supraglottic cancer. Incidence and mortality rates decreased for males with -2.5 and -2.8% per year, respectively, but remained stable for women, except for an increasing mortality rate in older women (EAPC: +2.5%). Five-year relative survival rates were stable for glottic (85%) and supraglottic (50%) cancer, whereas patients with high-staged cancers more often received radiotherapy. Multivariable analysis showed lower relative excess risks of dying for women, younger patients (<75 years), glottic cancer, lower stage cancer and those undergoing surgery. Changes in incidence and mortality rates are in line with changing smoking habits in The Netherlands. Declining incidence with stable survival rates gives rise to hope and worry at the same time.
© 2013 UICC.

Entities:  

Keywords:  cancer; incidence; larynx; mortality; survival; treatment; trends

Mesh:

Year:  2013        PMID: 23873096     DOI: 10.1002/ijc.28388

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Secular trends in the survival of patients with laryngeal carcinoma, 1995-2007.

Authors:  S D MacNeil; K Liu; S Z Shariff; A Thind; E Winquist; J Yoo; A Nichols; K Fung; S Hall; A X Garg
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  Assessing the applications of transitional care and its impact on the quality of life in patients after total laryngectomy.

Authors:  Yingchao Zhu; Dong Chen; Lili Jiang; Leilei Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Laryngeal function reconstruction with hyoid osteomuscular flap in partial laryngectomy for laryngeal cancer.

Authors:  Bojun Wei; Hong Shen; Hong Xie
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

4.  Incidence and mortality of laryngeal cancer in China, 2011.

Authors:  Lingbin Du; Huizhang Li; Chen Zhu; Rongshou Zheng; Siwei Zhang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

5.  Characteristics and outcome of laryngeal squamous cell carcinoma in young adults.

Authors:  Yuval Nachalon; Ohad Cohen; Uri Alkan; Jacob Shvero; Aron Popovtzer
Journal:  Oncol Lett       Date:  2016-12-21       Impact factor: 2.967

6.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

7.  The role of primary surgical treatment in young patients with squamous cell carcinoma of the larynx: a 20-year review of 34 cases.

Authors:  Junxi Wang; Xingguo Zhao; Xinliang Pan; Limin Zhao; Jianming Zhou; Min Ji
Journal:  World J Surg Oncol       Date:  2015-09-24       Impact factor: 2.754

8.  NBS1 rs2735383 polymorphism is associated with an increased risk of laryngeal carcinoma.

Authors:  Xinmei Hu; Juan Liao; Huiliu Zhao; Feng Chen; Xuefeng Zhu; Jiangheng Li; Qingqing Nong
Journal:  BMC Cancer       Date:  2018-02-12       Impact factor: 4.430

9.  Management of advanced laryngeal cancer.

Authors:  Patrick Sheahan
Journal:  Rambam Maimonides Med J       Date:  2014-04-28

10.  Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.

Authors:  Hai-Xu Wang; Chen Tang
Journal:  Oncol Rep       Date:  2017-06-29       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.